Table 1 Baseline characteristics and ACT scores
| Â | Recruited | Completed | ||||
|---|---|---|---|---|---|---|
| Â | Group A | Group B | p | Group A | Group B | p-value |
Number of patients | 600 | 663 | Â | 400 | 416 | Â |
Female %** | 58.80 | 55.70 | 0.26 | 59.80 | 57.90 | 0.60 |
Age range n (%) | ||||||
 18 to 30** | 55 (9.17) | 68 (10.26) | 0.96 | 32 (8.00) | 43 (10.34) | 0.69 |
 31 to 40** | 81 (13.50) | 89 (13.42) | 0.96 | 58 (14.50) | 62 (14.90) | 0.69 |
 41 to 50** | 117 (19.50) | 122 (18.40) | 0.96 | 79 (19.75) | 77 (18.51) | 0.69 |
 51 to 60** | 114 (19.00) | 125 (18.85) | 0.96 | 73 (18.25) | 80 (19.23) | 0.69 |
 61 to 70** | 125 (20.83) | 136 (20.51) | 0.96 | 82 (20.50) | 77 (18.51) | 0.69 |
 71 to 80** | 83 (13.83) | 88 (13.27) | 0.96 | 59 (14.75) | 52 (12.50) | 0.69 |
 Over 81** | 25 (4.17) | 35 (5.28) | 0.96 | 17 (4.25) | 25 (6.01) | 0.69 |
ACT scores | ||||||
 Median (IQR)* | 19 (14.25–23) | 17 (17–21) | <0.01 | 19 (15–23) | 18 (18–24) | <0.01 |
 5–14 not controlled n(%)** | 150 (25.00) | 203 (30.60) | <0.01 | 91 (22.80) | 121 (29.10) | 0.01 |
 15–19 partially controlled n(%)** | 177 (29.50) | 223 (33.60) | <0.01 | 114 (28.50) | 132 (31.60) | 0.01 |
 20–25 controlled n(%)** | 273 (45.50) | 237 (35.71) | <0.01 | 195 (48.70) | 163 (39.30) | 0.01 |